The recent report is published by the Qualiket Research on the global multiplexed diagnostic market, which delivers detailed analysis of segments and sub-segments in global as well as regional level. The study also highlights the impact of COVID-19 on the global multiplexed diagnostic market during this forecast timeline.
The multiplexed diagnostic is used for the analysis of the biological samples which can complete a screening process with a single run. The multiplexed diagnostics assays are involved in the diagnosis and detection of various diseases and infections such as autoimmune diseases, allergies, cancer, and cardiovascular diseases.
The increase in private and public funding for genomics and personalized medicine is the key driving factor which expected to boost the global multiplexed diagnostic market growth during this forecast timeline. Furthermore, the rise in demand for automated equipment and multifaceted analytical strategies will positively influence the market growth. Also, the growing demand for advanced diagnostic technology for accurate diagnosis of life threatening diseases expected to propel the global multiplexed diagnostic market growth. Moreover, the favorable regulatory scenario for new product launch activities, and multiple usage of multiplexed diagnostics technology are some driving factors which are responsible for the market growth in near future.
Lack of skilled professionals is the major restraint which is expected to hamper the global multiplexed diagnostic market growth. Also, lack of advanced infrastructure and high initial cost will limit the market growth over the forecast period.
The Global Multiplexed Diagnostic Market is segmented into product type, application, end user, and region.
On the basis of product type, the global multiplexed diagnostic market is segmented into Reagents & Consumables, and Instruments.
On the basis of application, the global multiplexed diagnostic market is segmented into Disease Diagnostics, Molecular Diagnostics, and Drug Development.
On the basis of end user, the global multiplexed diagnostic market is segmented into Hospitals, Clinical Laboratories, Academic & Research Institutes, and Others.
On the basis region, the global multiplexed diagnostic market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in global multiplexed diagnostic market report are Thermo Fisher, Hoffmann-La Roche Ltd., BioMerieux SA, Agilent technologies, Abbott Laboratories, Qiagen N.V., Bio-Rad Laboratories, Inc., Illumine Inc., Siemens AG etc.
The North America is the major revenue contributor in the global multiplexed diagnostic market due to the increase in awareness, significant healthcare spending in overall national budgets, and the increase in adoption of advanced technologies. Also, Asia Pacific is considered as the most lucrative market over the forecast period from 2020 to 2027, due to the increase in private and public investment in life science research, technological advancements, and the improving healthcare infrastructure.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Multiplexed Diagnostic Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Multiplexed Diagnostic Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Multiplexed Diagnostic Market Share Analysis, By Product Type
5.3 Global Multiplexed Diagnostic Market Size and Forecast, By Product Type
5.3.1 Reagents & Consumables
5.3.2 Instruments
6 Global Multiplexed Diagnostic Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Multiplexed Diagnostic Market Share Analysis, By Application
6.3 Global Multiplexed Diagnostic Market Size and Forecast, By Application
6.3.1 Disease Diagnostics
6.3.2 Molecular Diagnostics
6.3.3 Drug Development
7 Global Multiplexed Diagnostic Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Multiplexed Diagnostic Market Share Analysis, By End User
7.3 Global Multiplexed Diagnostic Market Size and Forecast, By End User
7.3. 1 Hospitals
7.3.2 Clinical Laboratories
7.3.3 Academic & Research Institutes
7.3.4 Others
8Global Multiplexed Diagnostic Market, By Region
8.1 Global Multiplexed Diagnostic Market Share Analysis, By Region
8.2 Global Multiplexed Diagnostic Market Share Analysis, By Region
8.3 Global Multiplexed Diagnostic Market Size and Forecast, By Region
9 North America Multiplexed Diagnostic Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Multiplexed Diagnostic Market Share Analysis, By Product Type
9.3 North America Multiplexed Diagnostic Market Size and Forecast, By Application
9.4 North America Multiplexed Diagnostic Market Size and Forecast, By End User
9.5 North America Multiplexed Diagnostic Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeMultiplexed Diagnostic Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Multiplexed Diagnostic Market Share Analysis, By Product Type
10.3 Europe Multiplexed Diagnostic Market Size and Forecast, By Application
10.4 Europe Multiplexed Diagnostic Market Size and Forecast, By End User
10.5 Europe Multiplexed Diagnostic Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Multiplexed Diagnostic Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Multiplexed Diagnostic Market Share Analysis, By Product Type
11.3 Asia Pacific Multiplexed Diagnostic Market Size and Forecast, By Application
11.4 Asia Pacific Multiplexed Diagnostic Market Size and Forecast, By End User
11.5 Asia Pacific Multiplexed Diagnostic Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Multiplexed Diagnostic Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Multiplexed Diagnostic Market Share Analysis, By Product Type
12.3 Latin America Multiplexed Diagnostic Market Size and Forecast, By Application
12.4 Latin America Multiplexed Diagnostic Market Size and Forecast, By End User
12.5 Latin America Multiplexed Diagnostic Market Size and Forecast, Country
13Middle East Multiplexed Diagnostic Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Multiplexed Diagnostic Market Share Analysis, By Product Type
13.3 Middle East Multiplexed Diagnostic Market Size and Forecast, By Application
13.4 Middle East Multiplexed Diagnostic Market Size and Forecast, By End User
13.5 Middle East Multiplexed Diagnostic Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Thermo Fisher
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Hoffmann-La Roche Ltd
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. BioMerieux SA
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Agilent technologies
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Abbott Laboratories
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Qiagen N.V.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Bio-Rad Laboratories, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Illumine Inc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Siemens AG
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
